Development of a symptom index for patients with primary brain tumors

Value in Health

Volumn 17, Issue 1, 2014, Pages 62-69

  Lai, Jin Shei ^a   Jensen, Sally E ^a   Beaumont, Jennifer L ^a   Abernethy, Amy P ^b   Jacobsen, Paul B ^c   Syrjala, Karen ^d   Raizer, Jeffrey J ^a   Cella, David ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

health related quality of life; NFBrSI 24; primary brain tumor; symptom index

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN TUMOR; CANCER PATIENT; CHECKLIST; CONVERGENT VALIDITY; EMOTION; FEMALE; FUNCTIONAL ASSESSMENT; FUNCTIONAL STATUS; HUMAN; INTERNAL CONSISTENCY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NATIONAL COMPREHENSIVE CANCER NETWORK FUNCTIONAL ASSESSMENT OF CANCER THERAPY BRAIN SYMPTOM INDEX; PHYSICAL ACTIVITY; PRIMARY TUMOR; PRIORITY JOURNAL; QUALITY OF LIFE; SOCIAL STATUS; SYMPTOM;

HEALTH-RELATED QUALITY OF LIFE; NFBRSI-24; PRIMARY BRAIN TUMOR; SYMPTOM INDEX;

ADULT; AGED; BRAIN NEOPLASMS; CHECKLIST; FEMALE; HEALTH STATUS INDICATORS; HUMANS; INTERVIEWS AS TOPIC; MALE; MIDDLE AGED; NEOPLASM STAGING; QUALITY OF LIFE; QUESTIONNAIRES;

EID: 84892594011     PISSN: 10983015     EISSN: 15244733     Source Type: Journal    
DOI: 10.1016/j.jval.2013.11.006     Document Type: Article

References (38)

1. Howlader N, Noone AM, Krapcho M, et al. SEER cancer statistics review, 1975-2009 (vintage 2009 populations) based on November 2011 SEER data submission, posted to the SEER web site, April 2012. 2012. Available from: http://seer.cancer.gov/csr/1975-2009-pops09/. [Accessed on April 1, 2013].
2. T.S. Armstrong, E. Vera-Bolanos, and I. Gning et al. The impact of symptom interference using the MD Anderson Symptom Inventory-Brain Tumor Module (MDASI-BT) on prediction of recurrence in primary brain tumor patients Cancer 117 2011 3222 3228
3. R.K. Portenoy, H.T. Thaler, and A.B. Kornblith et al. Symptom prevalence, characteristics and distress in a cancer population Qual Life Res 3 1994 183 189
4. R.K. Portenoy, H.T. Thaler, and A.B. Kornblith et al. The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress Eur J Cancer 30A 1994 1326 1336
5. D. Cella The FDA and the person with cancer Oncology 20 2006 436
6. C. Quinten, J. Maringwa, and C.C. Gotay et al. Patient self-reports of symptoms and clinician ratings as predictors of overall cancer survival J Natl Cancer Inst 103 2011 1851 1858
7. L.S. Fish, and B.E. Lewis Quality of life issues in the management of ovarian cancer Semin Oncol 26 1, Suppl. 1 1999 32 39
8. H.J. Sutherland, G.A. Lockwood, and N.F. Boyd Ratings of the importance of quality of life variables: therapeutic implications for patients with metastatic breast cancer J Clin Epidemiol 43 1990 661 666
9. H.A. Burris III, M.J. Moore, and J. Andersen et al. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial J Clin Oncol 15 1997 2403 2413
10. C. Quinten, C. Coens, and M. Mauer et al. Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trials Lancet Oncol 10 2009 865 871
11. N.K. Aaronson, S. Ahmedzai, and B. Bergman et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology J Natl Cancer Inst 85 1993 365 376
12. D. Cella Assessment methods for quality of life in cancer patients: the FACIT measurement system Int J Pharm Med 14 2000 78 81
13. D. Cella Manual of the Functional Assessment of Chronic Illness Therapy (FACIT Scales) Version 4 1997 FACIT.org Elmhurst, IL
14. S.X. Kong, and S.K. Gandhi Methodologic assessments of quality of life measures in clinical trials Ann Pharmacother 31 1997 830 836
15. M.A. Weitzner, C.A. Meyers, and C.K. Gelke et al. The Functional Assessment of Cancer Therapy (FACT) scale. Development of a brain subscale and revalidation of the general version (FACT-G) in patients with primary brain tumors Cancer 75 1995 1151 1161
16. T. Armstrong, T. Mendoza, and I. Gning et al. Validation of the M.D. Anderson Symptom Inventory Brain Tumor Module (MDASI-BT) J Neurooncol 80 2006 27 35
17. M.J.B. Taphoorn, L. Claassens, and N.K. Aaronson et al. An international validation study of the EORTC brain cancer module (EORTC QLQ-BN20) for assessing health-related quality of life and symptoms in brain cancer patients Eur J Cancer 46 2010 1033 1040
18. D. Cella, D. Paul, and S. Yount et al. What are the most important symptom targets when treating advanced cancer? A survey of providers in the National Comprehensive Cancer Network (NCCN) Cancer Invest 21 2003 526 535
19. C. Brunelli, M. Costantini, and P. Di Giulio et al. Quality-of-life evaluation: when do terminal cancer patients and health-care providers agree? J Pain Symptom Manage 15 1998 151 158
20. A.C. Justice, L. Rabeneck, and R.D. Hays et al. Sensitivity, specificity, reliability, and clinical validity of provider-reported symptoms: a comparison with self-reported symptoms J Acquir Immune Defic Syndr 21 1999 126 133
21. C.L. Nekolaichuk, E. Bruera, and K. Spachynski et al. A comparison of patient and proxy symptom assessments in advanced cancer patients Palliat Med 13 1999 311 323
22. A.S. Stromgren, M. Groenvold, A. Sorensen, and L. Andersen Symptom recognition in advanced cancer. A comparison of nursing records against patient self-rating Acta Anaesthesiol Scand 45 2001 1080 1085
23. US Food and Drug Administration. Guidance for industry. Patient-reported outcome measures: use in medical product development to support labeling claims. 2009. Available from: http://www.fda.gov/downloads/Drugs/ GuidanceComplianceRegulatoryInformation/Guidances/UCM071975.pdf. [Accessed November 26, 2011].
24. D. Cella, S.K. Rosenbloom, and J.L. Beaumont et al. Development and validation of 11 symptom indexes to evaluate response to chemotherapy for advanced cancer J Natl Compr Canc Netw 9 2011 268 278
25. A. Nickolov, J.L. Beaumont, and D. Victorson et al. Questionnaire and FACT-Br Symptom Index (FBrSI) in patients with recurrent high-grade gliomas J Support Oncol 3 Suppl. 2005 s34
26. D.F. Cella, D.S. Tulsky, and G. Gray et al. The Functional Assessment of Cancer Therapy scale: development and validation of the general measure J Clin Oncol 11 1993 570 579
27. S. Pickard, M. De Leon, T. Kohlmann, and D. Cella Psychometric comparison of the standard EQ-5D to a 5 level version in cancer patients Med Care 45 2007 259 263
28. J. Cahill, G. LoBiondo-Wood, N. Bergstrom, and T. Armstrong Brain tumor symptoms as antecedents to uncertainty: an integrative review J Nurs Scholarsh 44 2012 145 155
29. M.P. Lovely Symptom management of brain tumor patients Semin Oncol Nurs 20 2004 273 283
30. E.K. Fromme, K.M. Eilers, and M. Mori et al. How accurate is clinician reporting of chemotherapy adverse effects? A comparison with patient-reported symptoms from the Quality-of-Life Questionnaire C30 J Clin Oncol 22 2004 3485 3490
31. M.A. Petersen, M. Groenvold, and N. Aaronson et al. Multidimensional computerized adaptive testing of the EORTC QLQ-C30: basic developments and evaluations Qual Life Res 15 2006 315 329
32. C.M. Moinpour, and L.C. Lovato Ensuring the quality of quality of life data: the Southwest Oncology Group experience Stat Med 17 1998 641 651
33. D.W. Bruner, B. Movsas, and A. Konski et al. Outcomes Research in Cancer Clinical Trial Cooperative Groups: the RTOG model Qual Life Res 13 2004 1025 1041
34. A. Bottomley Developing clinical trial protocols for quality-of-life assessment Appl Clin Trials 10 2001 40 55
35. J.S. Lai, K. Dineen, and B. Reeve et al. An item response theory based pain item bank can enhance measurement precision J Pain Symptom Manage 30 2005 278 288
36. D.L. Fairclough, and D.F. Cella Functional Assessment of Cancer Therapy (FACT-G): non-response to individual questions Qual Life Res 5 1996 321 329
37. F. Rijmen, S. Rapp, E.H. Ip, and E.G. Shaw Qualitative longitudinal analysis of symptoms in patients with primary and metastatic brain tumours J R Stat Soc Ser A Stat Soc 171 2008 739 753
38. S. Rieken, D. Habermehl, and T. Haberer et al. Proton and carbon ion radiotherapy for primary brain tumors delivered with active raster scanning at the Heidelberg Ion Therapy Center (HIT): early treatment results and study concepts Radiat Oncol 7 2012 41